Dialogue Volume 14 Issue 3 2018 - Page 38

DISCIPLINE SUMMARIES ORDER The Discipline Committee ordered: immediate revo- cation of Dr. Ghabbour’s certificate of registration; a reprimand; and payment to the College for costs in the amount of $11,000. For complete details of the Order, please see the full decision at www.cpso.on.ca. Select Find a Doctor and enter the doctor’s name. At the conclusion of the hearing, Dr. Ghabbour waived his right to an appeal and the Committee administered the public reprimand. DR. MORY MAYER GUTMAN PRACTICE LOCATION: Toronto AREA OF PRACTICE: General Practice HEARING INFORMATION: Admission, Agreed Statement of Facts, Contested Penalty On August 24, 2017, the Discipline Committee found that Dr. Gutman committed an act of profes- sional misconduct in that he has engaged in conduct or an act or omission relevant to the practice of medicine that, having regard to all the circumstances, would reasonably be regarded by members as dis- graceful, dishonourable or unprofessional. Previous Discipline History with the College In 2011, an Order of the Discipline Committee pro- hibited Dr. Gutman from prescribing narcotic drugs/ preparations, controlled drugs, benzodiazepines and other targeted substances and he was prohibited from engaging in professional encounters with any female patients. Prescribing Contrary to the Discipline Committee’s Restrictions In January of 2013, the College received information from a pharmacist that Dr. Gutman had prescribed testosterone gel, which is a controlled substance, to a male patient in 2012 and 2013, contrary to the terms of his prescribing restriction. In May 2014, the Inquiries, Complaints and Re- 38 DIALOGUE ISSUE 3, 2018 ports Committee (ICRC) advised Dr. Gutman to be vigilant to ensure that he does not breach the terms of his certificate of registration. In 2016, information from the Narcotics Moni- toring System (NMS) for the time period of April 1, 2013 to August 13, 2015, was received by the College, raising concerns that Dr. Gutman had prescribed contrary to the terms of the Discipline Committee Order. The College commenced an investigation, which found that Dr. Gutman prescribed the following con- trolled substances: • Dr. Gutman prescribed ten repeats of testosterone gel to Patient A in October 2012. He was unaware that testosterone was a controlled substance and therefore a medication he was prohibited from prescribing. • Dr. Gutman prescribed Sublinox to:  atient B on two occasions in October 2014; – P  atient C on three occasions in September 2014; – P  atient D on two occasions (with 8 refills on a – P second occasion) in October 2014; – P  atient E on two occasions in February 2014 and in April 2016; – P  atient F on two occasions in October 2014 and April 2016.  D  r. Gutman was unaware that Sublinox was a controlled substance and therefore a medication that he was prohibited from prescribing. The prescrib- ing occurred prior to a pharmacist bringing to his attention that this substance was designated as a controlled drug. • Dr. Gutman authorized eight refills of phenobarbi- tal to an elderly patient who suffers from intellec- tual impairment and seizures in March 2014. Dr. Gutman was aware that phenobarbital is a con- trolled substance at the time he prescribed it. The prescribing occurred in error when Dr. Gutman was renewing batch prescriptions of medication prescribed by the patient’s previous physician. • Dr. Gutman prescribed Clobazam to a young man with recurrent seizures, on one occasion in Febru-